Gustavo Rubino de Azevedo Focchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gustavo Rubino de Azevedo Focchi has a total of 225 co-authors. Here are the top co-authors by number of shared publications:
Cristine Dobo
Department of Pathology, Federal University of São Paulo, UNIFESP, SP, Brazil
5 shared publications- Sergio Mancini Nicolau
Universidade Federal de São Paulo, Brazil; Hospital Sírio Libanês, Brazil
5 shared publications - Manuel de Jesus Simões
Universidade de São Paulo
4 shared publications - Neila Maria de Góis Speck
Universidade Federal de São Paulo
4 shared publications Celina T F Oshima
Department of Pathology, Federal University of São Paulo, UNIFESP, SP, Brazil
3 shared publications- Daniel Araki Ribeiro
Department of Biosciences Institute of Health and Society, Federal University of São Paulo, UNIFESP Santos São Paulo Brazil
3 shared publications
Latest Publications
- 11 July 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (11)
Lymphovascular space invasion in cervical cancer: beyond the binary
- 11 July 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (11)
Lymphovascular space invasion in cervical cancer: beyond the binary
- Open Access
- 15 September 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (9) , 1087
Efficacy of Fractional Laser on Steroid Receptors in GSM Patients
Background: To compare the efficacy of CO2 fractional laser with that of topical estriol for treating genitourinary syndrome of menopause and to investigate the relationship between epithelial thickness and vaginal atrophy. Methods: Twenty-five menopausal women were randomized to receive either laser or estrogen treatment. Vaginal biopsies before and after treatment were compared to assess the amount and distribution of estrogen and progesterone receptors. Results: Estrogen receptor levels were statistically similar between groups before and after treatment. Although there was no change over time in the estrogen group, an increase in receptor levels was confirmed in the laser group. Changes in estrogen receptor levels showed no association with treatment. Progesterone receptor levels were statistically similar between groups throughout treatment. There was no change over time in both groups. These changes displayed no association with the type of treatment. There was no significant correlation between epithelium thickness and estrogen or progesterone receptor levels. Conclusions: Estrogen and progesterone receptor levels increased and were maintained, respectively, in the vaginal epithelium in both groups. There was no significant relationship between epithelium thickness and receptor density. Laser therapy had similar outcomes to the gold standard without involving the disadvantages of hormone therapy.
- 15 September 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (9) , 1087
Open AccessEfficacy of Fractional Laser on Steroid Receptors in GSM Patients
Background: To compare the efficacy of CO2 fractional laser with that of topical estriol for treating genitourinary syndrome of menopause and to investigate the relationship between epithelial thickness and vaginal atrophy. Methods: Twenty-five menopausal women were randomized to receive either laser or estrogen treatment. Vaginal biopsies before and after treatment were compared to assess the amount and distribution of estrogen and progesterone receptors. Results: Estrogen receptor levels were statistically similar between groups before and after treatment. Although there was no change over time in the estrogen group, an increase in receptor levels was confirmed in the laser group. Changes in estrogen receptor levels showed no association with treatment. Progesterone receptor levels were statistically similar between groups throughout treatment. There was no change over time in both groups. These changes displayed no association with the type of treatment. There was no significant correlation between epithelium thickness and estrogen or progesterone receptor levels. Conclusions: Estrogen and progesterone receptor levels increased and were maintained, respectively, in the vaginal epithelium in both groups. There was no significant relationship between epithelium thickness and receptor density. Laser therapy had similar outcomes to the gold standard without involving the disadvantages of hormone therapy.
- Open Access
- 26 September 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (13)
Evaluation of surgery indication of cold knife conization and anatomopathological reports in patients with cervical squamous intraepithelial lesion or cervical cancer
O objetivo desse trabalho fundamentou-se em avaliar a concordância entre a indicação cirúrgica de conização clássica por citologia cervical (CC), biópsia ou excisão da zona de transformação (EZT), e o resultado anatomopatológico final das pacientes submetidas ao procedimento devido a lesões precursoras ou câncer do colo do útero. Além disso, visou observar a presença de lesão residual após EZT com diagnóstico histológico de carcinoma espinocelular (CEC) microinvasivo e margens comprometidas por lesão intraepitelial de alto grau (LIEAG). Para tal, realizou-se estudo retrospectivo envolvendo 82 mulheres com lesões intraepiteliais cervicais ou câncer com idade entre 28 e 71 anos. Estas foram submetidas a citologia cervicovaginal, biópsia de colo ou EZT entre janeiro de 2014 e janeiro de 2020 e tiveram a conização clássica indicada de acordo com os resultados dos procedimentos diagnósticos. A indicação cirúrgica foi a citologia em 30.5% dos casos; em 12.2%, foi devido à biópsia cervical, e em 24.4%, devido à citologia confirmada pela biópsia. Além disso, 32.9% das pacientes tiveram a cirurgia realizada devido a margens comprometidas após EZT. Foi encontrada concordância em 57.3% das indicações e 42.7% não apresentaram concordância. Observou-se lesão residual em 55.6% de todas as pacientes submetidas a EZT, mas no grupo de CEC microinvasivo, houve taxa de 60% de ausência de lesão residual na peça cirúrgica da conização. Portanto, isso indica que a EZT parece ser tratamento eficaz para o CEC microinvasivo do colo do útero, e uma cirurgia complementar parece não ser necessária na presença de margens comprometidas por LIEAG.
- 26 September 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (13)
Open AccessEvaluation of surgery indication of cold knife conization and anatomopathological reports in patients with cervical squamous intraepithelial lesion or cervical cancer
O objetivo desse trabalho fundamentou-se em avaliar a concordância entre a indicação cirúrgica de conização clássica por citologia cervical (CC), biópsia ou excisão da zona de transformação (EZT), e o resultado anatomopatológico final das pacientes submetidas ao procedimento devido a lesões precursoras ou câncer do colo do útero. Além disso, visou observar a presença de lesão residual após EZT com diagnóstico histológico de carcinoma espinocelular (CEC) microinvasivo e margens comprometidas por lesão intraepitelial de alto grau (LIEAG). Para tal, realizou-se estudo retrospectivo envolvendo 82 mulheres com lesões intraepiteliais cervicais ou câncer com idade entre 28 e 71 anos. Estas foram submetidas a citologia cervicovaginal, biópsia de colo ou EZT entre janeiro de 2014 e janeiro de 2020 e tiveram a conização clássica indicada de acordo com os resultados dos procedimentos diagnósticos. A indicação cirúrgica foi a citologia em 30.5% dos casos; em 12.2%, foi devido à biópsia cervical, e em 24.4%, devido à citologia confirmada pela biópsia. Além disso, 32.9% das pacientes tiveram a cirurgia realizada devido a margens comprometidas após EZT. Foi encontrada concordância em 57.3% das indicações e 42.7% não apresentaram concordância. Observou-se lesão residual em 55.6% de todas as pacientes submetidas a EZT, mas no grupo de CEC microinvasivo, houve taxa de 60% de ausência de lesão residual na peça cirúrgica da conização. Portanto, isso indica que a EZT parece ser tratamento eficaz para o CEC microinvasivo do colo do útero, e uma cirurgia complementar parece não ser necessária na presença de margens comprometidas por LIEAG.
- Open Access
- 1 August 2019
- Published by Elsevier in Gynecologic Oncology
- Vol. 154 (2) , 441-448
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
- 1 August 2019
- Published by Elsevier in Gynecologic Oncology
- Vol. 154 (2) , 441-448
Open AccessPathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
- 22 March 2018
- Published by S. Karger AG in Acta Cytologica
- Vol. 62 (2) , 104-114
Dual p16 and Ki-67 Expression in Liquid-Based Cervical Cytological Samples Compared to Pap Cytology Findings, Biopsies, and HPV Testing in Cervical Cancer Screening: A Diagnostic Accuracy Study
Objective: Our objective was to verify the sensitivity and specificity of dual immunocytochemistry staining for p16 and Ki-67 in liquid-based samples (the “dual” assay) for cervical lesion screening, compared to biopsy findings and human papillomavirus (HPV) DNA molecular detection. Study Design: Sensitivity, specificity, and positive (PPV) and negative (NPV) predictive values for the “dual immunocytochemistry assay” were calculated and compared to histopathological results and to high-risk HPV DNA detection in adult women or teenagers submitted to cervical cancer screening. Results: A total of 151 women were included. The majority (96.2%) of those with negative dual assay results had lower biopsy grades (p < 0.001). Women with cytology results suggestive of cervical cancer had positive dual immunocytochemistry assay results more frequently (p < 0.001), and these positive results were also significantly associated with biopsy findings (p < 0.001) and with high-risk genotype HPV infection (p = 0.007). Specificity and PPV for the dual assay were 0.972 (0.855–0.999) and 0.800 (0.284–0.995), respectively, and 1.000 (0.590–1.000) and 1.000 (0.631–1.000) for HPV detection. Conclusions: The dual immunocytochemistry assay had high specificity and PPV. It reveals a persistent HPV infection, avoiding the need for new tissue collections for biopsies or hybrid capture.
- 22 March 2018
- Published by S. Karger AG in Acta Cytologica
- Vol. 62 (2) , 104-114
Dual p16 and Ki-67 Expression in Liquid-Based Cervical Cytological Samples Compared to Pap Cytology Findings, Biopsies, and HPV Testing in Cervical Cancer Screening: A Diagnostic Accuracy Study
Objective: Our objective was to verify the sensitivity and specificity of dual immunocytochemistry staining for p16 and Ki-67 in liquid-based samples (the “dual” assay) for cervical lesion screening, compared to biopsy findings and human papillomavirus (HPV) DNA molecular detection. Study Design: Sensitivity, specificity, and positive (PPV) and negative (NPV) predictive values for the “dual immunocytochemistry assay” were calculated and compared to histopathological results and to high-risk HPV DNA detection in adult women or teenagers submitted to cervical cancer screening. Results: A total of 151 women were included. The majority (96.2%) of those with negative dual assay results had lower biopsy grades (p < 0.001). Women with cytology results suggestive of cervical cancer had positive dual immunocytochemistry assay results more frequently (p < 0.001), and these positive results were also significantly associated with biopsy findings (p < 0.001) and with high-risk genotype HPV infection (p = 0.007). Specificity and PPV for the dual assay were 0.972 (0.855–0.999) and 0.800 (0.284–0.995), respectively, and 1.000 (0.590–1.000) and 1.000 (0.631–1.000) for HPV detection. Conclusions: The dual immunocytochemistry assay had high specificity and PPV. It reveals a persistent HPV infection, avoiding the need for new tissue collections for biopsies or hybrid capture.
- Open Access
- 1 January 2016
- Published by Wiley in Disease Markers
- Vol. 2016, 1-8
Immunohistochemical Expression of VEGF and Podoplanin in Uterine Cervical Squamous Intraepithelial Lesions
VEGF and podoplanin (PDPN) have been identified as angiogenesis and/or lymphangiogenesis regulators and might be essential to restrict tumor growth, progression, and metastasis. In the present study, we evaluate the association between the expression of these markers and CIN grade. Immunohistochemistry was performed in 234 uterine cervical samples using conventional histologic sections or TMA with the monoclonal antibodies to VEGF (C-1 clone) and podoplanin (D2-40 clone). Positive-staining rates of VEGF in 191 CIN specimens were significantly associated with histological grade (). Negative and/or focal immunostaining for PDPN were more frequent in CIN 3 (). We found that patients with CIN 3 more frequently had strong and more diffuse staining for VEGF and diminished staining for PDPN (). Strong and more diffuse VEGF immunoexpressions in CIN 2 and CIN 3 were detected when compared to CIN 1. Negative and/or focal PDPN immunoexpression appear to be more frequent in CIN 3. Moderate to strong VEGF expression may be a tendency among patients with high-grade lesions and diminished PDPN expression.- 1 January 2016
- Published by Wiley in Disease Markers
- Vol. 2016, 1-8
Open AccessImmunohistochemical Expression of VEGF and Podoplanin in Uterine Cervical Squamous Intraepithelial Lesions
VEGF and podoplanin (PDPN) have been identified as angiogenesis and/or lymphangiogenesis regulators and might be essential to restrict tumor growth, progression, and metastasis. In the present study, we evaluate the association between the expression of these markers and CIN grade. Immunohistochemistry was performed in 234 uterine cervical samples using conventional histologic sections or TMA with the monoclonal antibodies to VEGF (C-1 clone) and podoplanin (D2-40 clone). Positive-staining rates of VEGF in 191 CIN specimens were significantly associated with histological grade (). Negative and/or focal immunostaining for PDPN were more frequent in CIN 3 (). We found that patients with CIN 3 more frequently had strong and more diffuse staining for VEGF and diminished staining for PDPN (). Strong and more diffuse VEGF immunoexpressions in CIN 2 and CIN 3 were detected when compared to CIN 1. Negative and/or focal PDPN immunoexpression appear to be more frequent in CIN 3. Moderate to strong VEGF expression may be a tendency among patients with high-grade lesions and diminished PDPN expression. - Open Access
- 1 January 2016
- Published by Genetics and Molecular Research in Genetics and Molecular Research
- Vol. 15 (1)
Immunoexpression of HPV 16/18 E6 and E7 oncoproteins in high-grade cervical squamous intraepithelial lesions in HIV-positive women
The aim of this study was to assess the immunoexpression of human papillomavirus genotypes 16 and 18 (E6 and E7) oncoproteins in cervical high-grade squamous intraepithelial lesions (HSIL) of human immunodeficiency virus (HIV)-positive women. These results were also compared to the persistence and/or recurrence of lesions after loop electrosurgical excision procedure. Cervical samples from 158 patients were divided into three groups according to the presence or absence of HSIL in women who were or were not HIV-positive. By using the tissue microarray technique, immunohistochemistry was performed to analyze the expression of HPV 16/18 E6 and E7 oncoproteins. Cervical samples from 95 HIV-positive women and 63 HIV-negative women were studied. A statistically significant difference was found in the immunoexpression of E6 and E7 oncoproteins in samples from HIV-positive women with HSIL and that of women with non-neoplastic tissue (P < 0.001). There was also a statistically significant correlation between the immunoexpression of E6 (P = 0.012) and E7 (P < 0.001) oncoproteins in lesion persistence among HIV-positive women. Within the limitations of this study, the immunoexpression of HPV 16/18 E6 and E7 oncoproteins may have prognostic value regarding lesion persistence in HIV-positive women.
- 1 January 2016
- Published by Genetics and Molecular Research in Genetics and Molecular Research
- Vol. 15 (1)
Open AccessImmunoexpression of HPV 16/18 E6 and E7 oncoproteins in high-grade cervical squamous intraepithelial lesions in HIV-positive women
The aim of this study was to assess the immunoexpression of human papillomavirus genotypes 16 and 18 (E6 and E7) oncoproteins in cervical high-grade squamous intraepithelial lesions (HSIL) of human immunodeficiency virus (HIV)-positive women. These results were also compared to the persistence and/or recurrence of lesions after loop electrosurgical excision procedure. Cervical samples from 158 patients were divided into three groups according to the presence or absence of HSIL in women who were or were not HIV-positive. By using the tissue microarray technique, immunohistochemistry was performed to analyze the expression of HPV 16/18 E6 and E7 oncoproteins. Cervical samples from 95 HIV-positive women and 63 HIV-negative women were studied. A statistically significant difference was found in the immunoexpression of E6 and E7 oncoproteins in samples from HIV-positive women with HSIL and that of women with non-neoplastic tissue (P < 0.001). There was also a statistically significant correlation between the immunoexpression of E6 (P = 0.012) and E7 (P < 0.001) oncoproteins in lesion persistence among HIV-positive women. Within the limitations of this study, the immunoexpression of HPV 16/18 E6 and E7 oncoproteins may have prognostic value regarding lesion persistence in HIV-positive women.
- Open Access
- 1 March 2015
- Published by FapUNIFESP (SciELO) in Einstein (São Paulo)
- Vol. 13 (1) , 52-57
Cervical cancer screening in young and elderly women of the Xingu Indigenous Park: evaluation of the recommended screening age group in Brazil
Objective To analyze the occurrence of atypia in the cytology/histology examinations of young women under the age of 25 years and of elderly women aged over 64 years, in the Xingu Indigenous Park and to evaluate, in a subjective manner, if the age range for screening established by the Ministry of Health and the Instituto Nacional de Câncer is appropriate for this population. Methods The Xingu/UNIFESP Project, in partnership with the Center for Gynecological Disease Prevention, develops programs to prevent cervical cancer. The exploratory, retrospective and descriptive study of cytological and histopathological examinations of young (12-24 years) and elderly (aged 64 and over) women of the Xingu Indigenous Park, between 2005 and 2011. Results There was low occurrence of cytological atypia in the elderly female population, but there were occasional high-grade lesions in the indigenous youth. Conclusion Interrupting screening at the limit age of 64 years, as established by the Ministry of Health and the Instituto Nacional de Câncer is justified. However, screening of young women should begin at an earlier age.
- 1 March 2015
- Published by FapUNIFESP (SciELO) in Einstein (São Paulo)
- Vol. 13 (1) , 52-57
Open AccessCervical cancer screening in young and elderly women of the Xingu Indigenous Park: evaluation of the recommended screening age group in Brazil
Objective To analyze the occurrence of atypia in the cytology/histology examinations of young women under the age of 25 years and of elderly women aged over 64 years, in the Xingu Indigenous Park and to evaluate, in a subjective manner, if the age range for screening established by the Ministry of Health and the Instituto Nacional de Câncer is appropriate for this population. Methods The Xingu/UNIFESP Project, in partnership with the Center for Gynecological Disease Prevention, develops programs to prevent cervical cancer. The exploratory, retrospective and descriptive study of cytological and histopathological examinations of young (12-24 years) and elderly (aged 64 and over) women of the Xingu Indigenous Park, between 2005 and 2011. Results There was low occurrence of cytological atypia in the elderly female population, but there were occasional high-grade lesions in the indigenous youth. Conclusion Interrupting screening at the limit age of 64 years, as established by the Ministry of Health and the Instituto Nacional de Câncer is justified. However, screening of young women should begin at an earlier age.
- 1 February 2015
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 25 (2) , 269-278
Immunohistochemical Expression of Heparanases 1 and 2 in Benign Tissue and in Invasive Neoplasia of the Endometrium
- 1 February 2015
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 25 (2) , 269-278
Immunohistochemical Expression of Heparanases 1 and 2 in Benign Tissue and in Invasive Neoplasia of the Endometrium
- Open Access
- 1 January 2015
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Autopsy Case Reports
- Vol. 5 (2) , 41-44
An interesting finding in the uterine cervix: Schistosoma hematobium calcified eggs
Schistosoma hematobium infection is an endemic parasitic disease in Africa, which is frequently associated with urinary schistosomiasis. The parasite infection causes epithelial changes and disruption, facilitating the infection by the human papilloma virus and human immunodeficiency virus (HIV). The authors report the case of a 44-year-old African HIV-positive woman who presented an abnormal routine Pap smear. Colposcopy examination revealed dense acetowhite micropapillary epithelium covering the ectocervix, iodine-negative, an erosion area in endocervical canal, and atypical vessels. Histologic examination of the surgical specimens showed numerous calcified schistosome eggs (probably S. hematobium) and a high-grade cervical intraepithelial neoplasia. The relation between S. hematobium infection and bladder cancer is well known; however, this relationship with cervical cancer remains controversial. The symptoms of schistosomiasis of the female genital tract are rather non-specific, and are often misdiagnosed with other pelvic diseases. The familiarity of health professionals with schistosomiasis of the female genital tract is less than expected, even in endemic regions. Therefore, great awareness of this differential diagnosis in routine gynecological practice is of paramount importance.
- 1 January 2015
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Autopsy Case Reports
- Vol. 5 (2) , 41-44
Open AccessAn interesting finding in the uterine cervix: Schistosoma hematobium calcified eggs
Schistosoma hematobium infection is an endemic parasitic disease in Africa, which is frequently associated with urinary schistosomiasis. The parasite infection causes epithelial changes and disruption, facilitating the infection by the human papilloma virus and human immunodeficiency virus (HIV). The authors report the case of a 44-year-old African HIV-positive woman who presented an abnormal routine Pap smear. Colposcopy examination revealed dense acetowhite micropapillary epithelium covering the ectocervix, iodine-negative, an erosion area in endocervical canal, and atypical vessels. Histologic examination of the surgical specimens showed numerous calcified schistosome eggs (probably S. hematobium) and a high-grade cervical intraepithelial neoplasia. The relation between S. hematobium infection and bladder cancer is well known; however, this relationship with cervical cancer remains controversial. The symptoms of schistosomiasis of the female genital tract are rather non-specific, and are often misdiagnosed with other pelvic diseases. The familiarity of health professionals with schistosomiasis of the female genital tract is less than expected, even in endemic regions. Therefore, great awareness of this differential diagnosis in routine gynecological practice is of paramount importance.